Company intelligence / Profile preview

Indovax

Gurugram/Gurgaon, Haryana, Indiaindovax.com ↗

Ownership: Private
Employees: ~79
Development stage: Commercial

Overview

Indovax has over three decades of experience developing and manufacturing both live and inactivated vaccines for the prevention of major poultry diseases. Its products are widely used across India and exported to several countries in Africa and Asia. The company played a pivotal role in controlling outbreaks like Gumboro disease with its proprietary IV95 vaccine.

Therapeutic areas: Infectious Diseases
Modalities: Vaccine (Live)Vaccine (Inactivated)Biologic
Industry: Veterinary

Drug pipeline

3 assets

F Strain

Commercial

Indications: Poultry diseases

2 more assets in the full pipeline.

Request access →

Partnerships

Initial collaboration with Vineland Laboratories, USA

Beyond the preview

Go deeper on Indovax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indovax.

Explore the full profile